Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

509 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Safety and Efficacy of Radiation Therapy with Concurrent Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin-Based Systemic Therapy for Multiple Myeloma.
Nehlsen AD, Sindhu KK, Moshier E, Richter J, Richard S, Chari A, Sanchez L, Parekh S, Cho HJ, Jagannath S, Dharmarajan K. Nehlsen AD, et al. Among authors: jagannath s. Clin Lymphoma Myeloma Leuk. 2022 Mar;22(3):192-197. doi: 10.1016/j.clml.2021.09.015. Epub 2021 Sep 24. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34736880 Free PMC article.
The role of thalidomide in multiple myeloma.
Schwab C, Jagannath S. Schwab C, et al. Among authors: jagannath s. Clin Lymphoma Myeloma. 2006 Jul;7(1):26-9. doi: 10.3816/CLM.2006.n.035. Clin Lymphoma Myeloma. 2006. PMID: 16879766 Review.
Bortezomib dosing in relapsed multiple myeloma.
Jagannath S. Jagannath S. Clin Lymphoma Myeloma. 2006 Sep;7(2):101-2. doi: 10.3816/CLM.2006.n.045. Clin Lymphoma Myeloma. 2006. PMID: 17026818 No abstract available.
Progress in multiple myeloma.
Jagannath S. Jagannath S. Clin Lymphoma Myeloma. 2008 Aug;8(4):202-4. doi: 10.3816/CLM.2008.n.027. Clin Lymphoma Myeloma. 2008. PMID: 18765306 No abstract available.
Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma.
Bensinger WI, Jagannath S, Vescio R, Camacho E, Wolf J, Irwin D, Capo G, McKinley M, Potts P, Vesole DH, Mazumder A, Crowley J, Becker P, Hilger J, Durie BG. Bensinger WI, et al. Among authors: jagannath s. Br J Haematol. 2010 Feb;148(4):562-8. doi: 10.1111/j.1365-2141.2009.07981.x. Epub 2009 Nov 16. Br J Haematol. 2010. PMID: 19919652 Free article. Clinical Trial.
509 results